EPILEPSY 8.1 Temporal Lobe Epilepsy A 25-year-old woman had repeated episodes of the sudden onset of fear on unpleasant odor. These were followed by her losing consciousness for several minutes and making bizarre lip-smacking movements. Images 8.1A–8.1C: Coronal T2-weighted and coronal and axial FLAIR images demonstrate hyperintensity and atrophy of the right hippocampus (red arrow). Mild enlargement of the temporal horn is noted. Image 8.1D: Pathological demonstration of hippocampal sclerosis (image courtesy of Dr. Seema Shroff, Fellow, Neuropathology, NYULMC). A seizure is defined by the International League Against Epilepsy (ILAE) as “abnormal excessive or synchronous neuronal activity in the brain.” Epilepsy is defined as recurrent, unprovoked seizures due to inherent neuronal hyperexcitability. Seizures can be provoked or unprovoked. Examples of provoked seizures include metabolic derangements, such as hyponatremia, drug withdrawal (alcohol and benzodiazepines being the most common), or drug intoxication. The lifetime risk of epilepsy is about 3% and about 10% of adults will have a seizure at some point in their lives. The rate of epilepsy is high in early childhood (ages 0–14.) In children, genetic factors, congenital malformations, trauma, and neoplasms are the cause of most seizures. The risk of epilepsy declines significantly until the age of 60, at which vascular disease, neoplasms, trauma, infections, and neurodegenerative disorders are responsible for most seizures. In this age group, vascular disease is the leading cause of seizures, accounting for over 50%. There are two broad classifications of epilepsy: focal and generalized seizures. Focal seizures are those that have their onset at a specific brain location due to some localized pathology of the cerebral cortex. These may be related to some focal brain lesion such as an infection, tumor, or injury, though in most cases the cause is unknown. Partial seizures are further divided into simple and complex seizures, depending on whether or not a patient’s consciousness is impaired. A simple partial seizure does not affect consciousness. Partial seizures may manifest with motor, sensory, autonomic, or psychiatric symptoms, often a sense of overwhelming fear or depersonalization. Complex partial seizures affect consciousness and are most commonly associated with abnormalities of the medial temporal lobe. Simple partial seizures may spread and evolve into complex partial seizures. They may further spread throughout the entire brain, in which case they are called secondarily generalized seizures. An aura (warning) is an abnormal sensation that may precede a partial seizure. Primary generalized seizures involve both cerebral hemispheres at once without a localized area of onset. The etiology of these seizures is often hereditary. Auras do not occur in primarily generalized seizures. Generalized seizures, whether primary or secondary, always involve the impairment of consciousness, even if only for a few seconds. Types of primary generalized seizures include: Absence seizures: Absence seizures are divided into typical and atypical forms. Typical absence seizures are characterized by brief (less than 10 seconds) episodes of unresponsiveness after which patients rapidly return to baseline, often unaware that they had a seizure. There may be subtle eye-blinking or facial movements. These seizures can be provoked by hyperventilation or photic stimulation. Atypical absence seizures are longer (up to 30 seconds) with more pronounced motor movements, and postictal confusion. Myoclonic seizures: Myoclonic seizures are characterized by rapid, “shock-like” jerks of individual muscles or the entire body. Tonic–clonic seizures: In the tonic phase of the seizure, the patient abruptly loses consciousness followed by a loud vocalization (the epileptic cry) as air is expelled from the lungs against a close glottis. The skeletal muscles tense and the patient falls to the ground if standing. After 10 to 30 seconds, the clonic phase begins. It is characterized by dramatic muscle contraction and relaxation of progressively increasing duration. Patients may bite their tongues due to contracture of the jaw muscles, and the eyes are open in almost all cases. There are increases in heart rate, blood pressure, pupillary dilation, and salivation. The entire seizure lasts 1 to 3 minutes. Patients are often confused after the seizure, and in some cases may become frankly psychotic, a state termed postictal psychosis. Bowel and bladder incontinence are common in the postictal phase. Todd’s paralysis refers to motor weakness that persists after a seizure, sometimes as long as 24 hours. Patients may exhibit persistent symptoms other than weakness, such as aphasia, though this is less common. This is the most common type of seizure, experienced by about 10% of patients with epilepsy. Clonic seizures: Clonic seizures are similar to tonic seizures, but without the tonic component. They usually start before the age of 3. Tonic seizures: Tonic seizures are characterized by tonic spasms of the facial and truncal muscles, with flexion or extension of the extremities. The patient often falls to the ground, and serious injury may result. These seizures usually being in early childhood. Atonic seizures: Atonic seizures, also known as drop attacks, are characterized by the sudden weakness of postural muscles. They can be mild and result in a mere head drop, or severe and result in a complete loss of postural tone and severe injuries. The localized and generalized categories are divided into three further categories: idiopathic (unknown or inherited cause), symptomatic (identifiable cause), and cryptogenic (brain lesion is suspected, but cannot be identified). Another method of classifying seizures is by dividing them into epilepsy syndromes as defined by the ILAE. Epilepsy syndromes are defined by a cluster of features including the type of seizure, its localization, frequency, precipitating factors, age at onset, additional features of neurological or systemic disease, genetic factors, prognosis, and suggested treatments. West syndrome: West syndrome occurs in children aged 3 months to 2 years, most commonly in infants aged 8 to 9 months. It is defined by the triad of mental retardation, seizures known as infantile spasms (IS), and a pathognomonic EEG pattern (high-amplitude waves and a background of irregular spikes) called hypsarrhythmia. The most common cause is tuberous sclerosis, though it may be idiopathic. The prognosis is related to the underlying cause, though most children have significant cognitive disability and other seizures, including Lennox–Gastaut syndrome (LGS). It is treated with adrenocorticotropic hormone (ACTH) and conventional antiepileptic drugs (AEDs). Lennox–Gastaut syndrome: LGS develops in children aged 2 to 18 years old. It is characterized by a variety of generalized seizures (astatic seizures [drop attacks], tonic seizures, tonic–clonic seizures, atypical absence seizures, and less frequently, complex partial seizures) and developmental delay. The characteristic EEG shows slow spike-wave complexes of 2 Hz. AEDs are rarely effective in stopping the seizures. Juvenile myoclonic epilepsy: Juvenile myoclonic epilepsy (JME) is a primarily generalized epilepsy that develops in teenagers and young adults who are otherwise healthy and without neurological deficits. As the name implies, patients most often experience myoclonic jerks, though other seizure types occur as well. The jerks are most common early in the morning, and patients are often thought to “be clumsy.”The EEG has a characteristic pattern, showing generalized 4 to 6 Hz spike-wave discharges or multiple spike discharges. They are triggered by sleep deprivation, and a classic presentation is that of a teenager who has a generalized seizure after staying up all night. Patients will need lifelong treatment with AEDs, and avoidance of triggers, namely sleep deprivation. Benign centrotemporal epilepsy of childhood: Benign centrotemporal epilepsy of childhood (also known as benign Rolandic epilepsy) occurs in otherwise healthy children 3 to 13 years old. The seizures almost always occur at night and the most common type of seizure is a partial seizure involving the facial muscles. Speech arrest and drooling are common. For such seizures, no treatment is required, and the seizures always remit during puberty. In some circumstances, the seizures may generalize and AEDs may be required in such children. The characteristic EEG shows epileptic spike discharges originating from the centrotemporal scalp over the central sulcus (the Rolandic sulcus), which most commonly occur during the early stages of sleep. Benign occipital epilepsy of childhood: Benign occipital epilepsy of childhood (BOEC) occurs in children younger than 10 and is characterized by seizures on one half of the body and a variety of visual distortions including loss of vision or positive visual phenomena typically described in migraines, such as scintillating scotomas or brightly colored patterns or shapes (fortification spectra). As in migraines, headaches and nausea are common. The EEG reveals spikes originating from the occipital lobes. Landau–Kleffner syndrome: Landau–Kleffner syndrome (also known as acquired epileptic aphasia) is characterized by seizures and a progressive aphasia. It usually starts as a receptive aphasia, but may eventually develop into a global aphasia or even a complete auditory agnosia. It occurs in children between the ages of 5 and 7 who were previously healthy. Spontaneous remission may occur. Progressive myoclonic epilepsies: The progressive myoclonic epilepsies (PMEs) are a collection of disorders characterized by progressive cognitive decline and seizures. Myoclonic seizures are the most common, though tonic–clonic seizures may occur. Specific examples of PMEs include Unverricht–Lundborg disease (Baltic myoclonus); myoclonus epilepsy and ragged red fibers (MERRF); Lafora disease; neuronal ceroid lipofuscinosis; and type I Sialidosis. The most common of these is Unverricht–Lundborg disease, which occurs in children between ages 6 and 15. It is an autosomal-recessive inherited disorder that begins in children aged 6 to 18 with seizures and cognitive decline over the course of several decades. MERRF is a mitochondrial disorder characterized by both myoclonic and generalized tonic–clonic seizures (GTCs). Other features include developmental delay, deafness, and exercise intolerance. Febrile seizures: Febrile seizures occur in children aged 6 months to 6 years when there is a rapid rise in temperature. Boys are affected at twice the rate of girls. A simple febrile seizure is a generalized seizure that lasts less than 15 minutes (usually much less) and does not recur in a 24-hour period. In contrast, any seizure that is partial in onset, lasts for more than 15 minutes, or recurs in a 24-hour period is termed a complex febrile seizure. Risk factors for developing seizures later in life include complex partial seizures, an abnormal neurological exam, or nonfebrile seizures in a first degree relative. For most children, no treatment is required. Technically, febrile seizures are classified as a seizure condition that does not require the diagnosis of epilepsy. Reflex seizures: Reflex seizures are those which are triggered in response to a sensory stimulus. The stimuli are most commonly visual and include television and video games. Other stimuli known to cause seizures include reading and the startle response. Most seizures are generalized tonic–clonic. Symptomatic localization-related epilepsies: Symptomatic localization-related epilepsies are defined by the lobe of the brain in which the seizure originates. Epilepsies arising from lobes of the brain, other than the medial temporal lobes, are often due to tumors, infarcts, vascular malformations, traumatic injuries, or infectious processes such as neurocysticercosis. It is important to note that any lesion must affect the cerebral cortex in order to cause a seizure, and lesions of the white matter, basal ganglia, thalamus, and brainstem are not associated with seizures. Patients with seizures arising from the frontal lobes often have bizarre, seemingly purposeful motor behaviors that are often mistaken for nonepileptic seizures. Temporal lobe epilepsy (TLE) is a specific type of complex partial seizure, which as the name implies, arises from the medial temporal lobes. Though this is the most common origin of the focal epilepsies, other lobes of the brain can serve as seizure foci as well. The medial temporal lobe contains several important structures, namely the hippocampus, the amygdala, and the olfactory cortex. These structures are an integral part of the limbic system. The clinical features of the aura in patients with TLE reflect the anatomy of the medial temporal lobe. Déjà vu is a feeling of increased familiarity reflecting seizure activity in the hippocampus. Some patients experience the opposite, jamais vu, where familiar situations suddenly seem unrecognizable. Patients may also experience a strong feeling of fear due to activation of the amygdala, and patients may experience unpleasant odors, often described as if something is burning. Patients with TLE typically have a preceding aura, which can be: Somatosensory and special sensory: epigastric sensations or rising surge, metallic taste in mouth, strange smell, vertigo, visual, hearing Psychic: déjà vu (recalled emotions or memories), jamais vu (feelings of unfamiliarity), sudden intense emotions, depersonalization and derealization, extreme fear, anxiety Autonomic: abdominal pain, dilated eyes, sweating, piloerection, flushed face, nausea, palpitations, profuse salivation (slobbering), changes in heart rate Automatisms are also common in temporal lobe seizures. There can be oro-masticatory manual/pedalor reactive automatisms. Motionless stare, behavioral arrest, speech arrest, unilateral dystonic posturing, periods of confusion, disorientation, and decreased responsiveness are common clinical features seen during dyscognitive seizures. The MRI with epilepsy protocol includes T1-inversion prepared, gradient echo, echoplanar, true inversion recovery image, T2-fast spin echo, fluid-attenuated inversion recovery (FLAIR), and 3D volume acquisition of thin temporal cuts. The most common identifiable lesion on the brain MRI is mesial temporal sclerosis (MTS). In patients with TLE, subtle anatomic features of the medial temporal lobes and pathologies like MTS or incomplete hippocampal inversion are best appreciated in an oblique coronal plane. This orientation is orthogonal to the long axis of the temporal lobe and reduces volume averaging problems for the thin laminar appearance of the hippocampus. Oblique coronal temporal high-resolution T2-weighted and FLAIR are the best sequences to diagnose MTS. MTS is characterized by hippocampal atrophy, increased T2 signal, and abnormal morphology or loss of internal architecture of hippocampus. In 10% of the cases, MTS can be bilateral. Secondary findings may include dilatation of the temporal horn of the lateral ventricle, loss of gray–white matter differentiation in the temporal lobe, or decreased white matter in the adjacent temporal lobe (eg, collateral eminence and temporal stem). There can be atrophy of the ipsilateral fornix and mammillary body. High-resolution 3D T1-weighted images are also useful when performing hippocampal volumetric analyses. The presurgical evaluation is done to determine if the patient has a single epileptogenic focus that is not in “eloquent” cortex and can therefore be resected without causing an unacceptable neurological deficit. Corroborative evidence from various forms of noninvasive advanced imaging summarized in Table 8.1.1, the neuropsychological testing, and neuropsychiatric evaluation help determine whether a patient is a good surgical candidate or not. Seizures originating from medial temporal structures such as hippocampi are most amenable to surgical cure. Video EEG monitoring of patients’ typical seizures with scalp EEG is the cornerstone of the epilepsy surgery evaluation. Supervised medication withdrawal and provocation procedures (eg, sleep deprivation, hyperventilation, photic stimulation) are often necessary to facilitate seizures. In a patient presenting with a seizure, the first goal is to attend to a patient’s respiratory and cardiovascular status, and to terminate seizures if they are ongoing. In patients without a known history of epilepsy, investigations should be immediately undertaken to rule out potentially devastating and treatable conditions such as tumors, hemorrhages, metabolic derangements, or central nervous system (CNS) infections that can present with seizures. Table 8.1.1 Presurgical Evaluation of Patients With Focal Seizures MRI To look for any structural lesion such as MTS, cortical dysplasia, low-grade tumors (ganglioglioma, DNET etc.), malrotated hippocampus, encephalitis, cavernoma, AVM, or rare causes such as encephalocele of the sphenoid wing VEEG Differentiates epileptic from nonepileptic events; determines if seizures originate from a single focus or multiple foci Wada Language memory test; tells which side is controlling the language in the brain and gives individual scores of memory on each side of the brain PET Directly measures neurometabolic activity and receptor binding; regional reduction in glucose uptake (hypometabolism) during the interictal state in FDG-PET SPECT Hyperperfusion of the seizure focus MEG, MSI Localizes source of epileptiform discharges; when it is combined with structural imaging, it is called magnetic source imaging mainly used for co-registration with MRI to give MSI in three-dimensional space fMRI Identifies eloquent cortices such as language, motor, somatosensory, visual, auditory DWI Sensitive to the translational motion of water molecules in a lesion and helps identify strokes, neoplastic lesions, or abscesses DTI Helps precise delineation of white matter tracts in the brain; identifies eloquent white matter tracts, such as the arcuate fasciculus or the anterior extent of Meyer’s loop MRS Differentiates between dysplastic versus neoplastic masses, recurrent brain neoplasm versus radiation injury, or between an abscess versus a tumor; decreased NAA and decreased NAA/Cho and NAA/Cr ratios and decreased myoinositol in ipsilateral temporal lobe and increased lipid and lactate soon after a seizure AVM, arteriovenous malformation; DTI, diffusion tensor imaging; DWI, diffusion-weighted image; FDG-PET, fludeoxyglucose-PET; fMRI, functional magnetic resonance imaging; MEG, magnetoencephalogram; MRS, magnetic resonance spectroscopy; MSI, magnetic source imaging; NAA, N-acetyl aspartate; NAA/Cho, NAA/Choline; NAA/Cr, NAA/Creatine; SISCOM, subtraction ictal SPECT co-registered to MRI; SPECT, single photon emission computed tomography; VEEG, video EEG. Status epilepticus (SE) is a life-threatening condition defined as a seizure lasting longer than 30 minutes, or recurrent seizures without regaining consciousness between seizures for greater than 30 minutes. Benzodiazepines are the preferred initial management due to their rapid onset of action. Note that intravenous (IV) phenytoin cannot be given rapidly due to its risk for cardiac arrhythmias. Fosphenytoin can be given at triple the rate of phenytoin and can be given intramuscularly. The MRI findings for a patient who was in SE are shown. Images 8.1E and 8.1F: Coronal FLAIR and axial diffusion-weighted images demonstrate hyperintensity and multiple areas of restricted diffusion, primarily in the cortical ribbon of the right hemisphere. Epilepsia partialis continua refers to a persistent focal motor seizure, typically involving the hand, foot, or face. The mainstay of treatment is AEDs. These are summarized in Table 8.1.2. Women of childbearing age should have a pregnancy test prior to the initiation of any AED and clinicians must be aware that many AEDs lower the effectiveness of birth control medications. Most AEDs are teratogenic, though the vast majority of women have uncomplicated pregnancies. The risk of having uncontrolled seizures during pregnancy is considered more dangerous than the effects of medications, and the continued use of medications is suggested for most patients. All women in whom pregnancy is a possibility should be placed on high doses of folate to help minimize the risk of neural tube defects. Patients with epilepsy do not necessarily need to be on lifelong medications. Patients who have been seizure-free on medications for several years and have a normal neurological examination, MRI, and EEG may no longer need AEDs, and considering the side effects of these medications, attempts to lower or stop these medications are a reasonable action in many patients. Medications should be gradually lowered over the course of 3 to 4 months. The highest risk for seizure recurrence is in the first 3 months after medication discontinuation. There is some controversy over whether patients with a single seizure and no family history of seizures should be treated in the context of a normal neurological examination, EEG, and MRI. Most neurologists would not initiate treatment in such patients unless they had a second seizure. Approximately 30% of patients have seizures that are refractory to medical treatments. In these patients, surgical removal of epileptogenic foci can dramatically reduce or even eliminate seizures. Surgical removal of the temporal lobe is the most common surgical procedure in epilepsy and results in freedom from seizures in about 80% of patients, and a drastic reduction in seizure frequency in almost all patients. In this procedure, intracranial electrodes are implanted to try to localize the epileptogenic tissue. Functional studies such as PET and single photon emission computed tomography (SPECT) are used to help further localize the epileptic focus. Careful brain mapping of the proposed area of resection is required prior to any epilepsy surgery to ensure that patients are not left with severe language or cognitive deficits after the surgery. A Wada test is an injection of sodium amobarbital, a barbiturate, directly into one of the carotid arteries. This effectively sedates a single hemisphere of the brain allowing for memory and language functioning to be tested in each hemisphere. This helps ensure that eloquent brain areas are not removed. Additionally, electrocorticographic mapping on awake patients can be performed at the time of the operation to better delineate the function of exact brain areas prior to their potential resection. Table 8.1.2 Antiepileptic Medications Medication Indications Common/Concerning Side Effects Carbamazepine (Tegretol) Partial seizures Can worsen absence, myotonic, and atonic seizures; hyponatremia, vertigo, headache, ataxia, blood dyscrasias Oxcarbazepine (Trileptal) Partial seizures Can lead to hyponatremia, but does not affect the levels of other medications Lacosamide (Vimpat) Poorly controlled partial-onset seizures Phenytoin (Dilantin) Partial seizures, generalized tonic–clonic seizures, tonic and atonic seizures Gum hyperplasia, osteoporosis, hirsutism, rash with chronic use; ataxia, nystagmus, and confusion at high levels Lamotrigine (Lamictal) Effective in juvenile myoclonic epilepsy and Lennox–Gastaut syndrome Stevens–Johnson syndrome, especially if started at high doses; must be raised slowly to prevent rash Levetiracetam (Keppra) Partial-onset, myoclonic, or tonic–clonic seizures Depression, psychosis Eslicarbazepine (Aptiom) Partial-onset seizures as monotherapy or adjunctive therapy Dizziness, nausea, headache, and sedation Rufinamide (Banzel) Adjunctive treatment of seizures associated with Lennox–Gastaut syndrome in children 4 years and older and adults Sedation Tiagabine (Gabitril) Adjunctive treatment for partial seizures Sedation and cognitive slowing Gabapentin (Neurontin) Focal and partial seizures; neuropathic pain Dizziness, fatigue, depression Phenobarbital Used primarily in children in developing countries or to treat status epilepticus; used for all seizure types except absence Sedation and behavioral changes Pregabalin (Lyrica) Partial-onset seizures, neuropathic pain Poor memory, poor coordination, dry mouth, visual disturbances, and weight gain Topiramate (Topamax) Monotherapy in partial or mixed seizures, drop attacks in Lennox–Gastaut syndrome Nephrolithiasis, weight loss, cognitive slowing especially at higher doses Zonisamide (Zonegran) Adjunctive treatment in partial seizures Nephrolithiasis, weight loss Vigabatrin (Sabril) Infantile spasms due to tuberous sclerosis and adjunctive therapy for adult patients with refractory complex partial seizures Sedation, visual loss Felbamate (Felbatol) Partial and generalized seizures associated with Lennox–Gastaut syndrome Potentially fatal aplastic anemia and liver failure Clobazam (Onfi) Lennox–Gastaut syndrome in children older than 2; tonic–clonic, complex partial, and myoclonic seizures Tolerance and rebound seizures when discontinued Valproate (Depakote) Primary generalized epilepsies including absence, myoclonic, and tonic–clonic seizures Weight gain, pancreatitis, neural tube defects in pregnancy, hepatic toxicity in young children; interacts with many other antiepileptic drugs Perampanel (Fycompa) Refractory partial seizures Neuropsychiatric dysfunction, violent thoughts Ethosuximide (Zarontin) Used only in absence seizures Image 8.1G: Axial FLAIR image demonstrates hyperintensity of the right medial temporal lobe. Image 8.1H: Axial T2-weighted image demonstrates intracranial electrodes used to determine the seizure focus. Image 8.1I: Axial T2-weighted image demonstrates postoperative changes after a partial right temporal lobectomy. In patients for whom cortical areas cannot be removed without potentially devastating neurological impairment, a surgical technique known as multiple subpial transections is used to prevent seizure spread. It involves making a number of small incisions into the cerebral cortex with the hopes of disrupting epileptic circuits in the brain without impairing the function of the brain areas. This technique is most commonly employed in seizures that originate in brain areas responsible for language or motor function, which cannot be removed without significant neurological impairment. This surgical procedure is useful in seizure syndromes such as Landau–Kleffner syndrome, where surgery cannot be performed without potentially devastating the patient. In some patients with epilepsy refractory to medications, surgical lesions can be made in the corpus callosum to prevent seizures spreading from one hemisphere to the other. It is used almost exclusively in patients with generalized epilepsy with drop attacks. Vagus nerve stimulation involves implanting an electrode on the midcervical portion of the vagus nerve, which then sends intermittent electrical impulses through the nerve. VNS is recommended in patients with bilateral temporal seizure foci. Images 8.1J and 8.1K: Axial and sagittal T1-weighted images demonstrate anterior corpus callosotomy (red arrows). 1. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the International League Against Epilepsy. Epilepsia. 1989;30:389. 2. Berg AT, Berkovic SF, BrodieMJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676. 3. Abosch A, Bernasconi N, Boling W. Factors predictive of suboptimal seizure control following selective amygdalohippocampectomy. J Neurosurg. 2002;97(5):1142–1151. 4. Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. March 2012;307(9):922–930. 8.2 Frontal Lobe Epilepsy A 26-year-old presented with nocturnal hypermotor seizures with confusion and disorientation. Brain MRI showed an abnormal lesion. Images 8.2A and 8.2B: Serial axial FLAIR MRI of the frontal lobes (8.2A) and coronal FLAIR MRI (8.2B) demonstrating subtle gray–white blurring and FLAIR hyperintensity in the left anterior cingulate gyrus and adjacent left medial frontal gyrus from a pathologically proven cortical dysplasia (image courtesy of Timothy Shepherd, MD). Frontal lobe epilepsy is the second most common focal epilepsy after TLE. Patients tend to have stereotyped, hypermotor seizures typically during their sleep that are short-lasting (<30 seconds) compared to temporal lobe seizures; these are commonly confused with nonepileptic seizures (NES). Prominent motor manifestations, complex automatisms, and quick secondary generalization are common features of focal seizures with brief impairment of consciousness. Fencing posturing, speech arrest, eye deviation, facial grimacing, kicking, laughing, or other vocalizations are more common in frontal lobe seizures. Neuronal migrational disorders: Heterotopias are neuronal migrational disorders (NMDs) where gray matter gets arrested as neurons migrate from periventricular regions toward pia during embryonic stages. Heterotopias can either be focal, nodular, or multifocal (as in tuberous sclerosis) or preferentially involve one hemisphere as in hemimegalencephaly. Subcortical band heterotopias (SBHs) are typically periventricular, bilateral nodular collections of gray matter with relatively smooth margins, which gives the appearance of a double cortex. Pachygyria is abnormal tissue in the right location with abnormal sulcation and gyration of the mantle, which is typically thicker than 8 mm. Polymicrogyria (PMG) is either two- or four-layered cortex, which is less than 5 to 7 mm in thickness. Focal cortical dysplasias (FCDs) are classified into three categories (types I, II, and III) and further divided into various subtypes (Table 8.2.1) in a fully myelinated brain. Other important NMDs include lissencephaly, which is characterized by smooth brain surface, and abnormal gyration, which varies between agyria and pachygyria (Image 8.2C). Table 8.2.1 Classification of Focal Cortical Dysplasias Types Features Type I Ia: abnormal vertical alignment of neurons Ib: abnormal horizontal alignment Ic: horizontal and vertical malalignment Type II IIa: dysmorphic neurons without balloon cells IIb: dysmorphic neurons with balloon cells Type III IIIa: HS IIIb: glioneural tumors (eg, ganglioglioma, DNET) IIIc: vascular malformations (CCMs, AVMs, telangiectasias, meningioangiomatosis) IIId: prenatal or perinatal ischemic injury, TBI, scars due to inflammatory or infectious lesions AVMs, arteriovenous malformations; CCMs, cerebral cavernous malformations; DNETs, dysembryoplastic neuroepithelial tumors; HS, hippocampal sclerosis; TBI, traumatic brain injury. Lissencephaly with posteriorly predominant gyral abnormalities is caused by mutations in the LIS1 gene. Anteriorly predominant lissencephaly in heterozygous males and SBH in heterozygous females are caused by mutations of the XLIS (double cortex gene on chromosome X). Schizencephaly is another rare form of MCD, which is characterized by the presence of a transcortical cleft, which can extend from ventricles to the pia with open or fused lips, and often PMG is seen on the lips of the schizencephaly (Image 8.2D). Hemimegalencephaly is the unilateral hamartomatous excessive growth of all or part of one cerebral hemisphere at different phases of embryonic development. MRI in these cases reveals an enlarged hemisphere with increased white matter volume, cortical thickening, agyria, pachygyria, PMG, or lissencephaly and blurring of the gray–white matter junction. Often, a large, ipsilateral irregularly shaped ventricle may be seen. Most FCD types present with intractable seizures with or without mild to severe learning disabilities. Bilateral perisylvian PMG due to mutation in MECP2 gene can present with dysarthria, pseudobulbar palsy, spastic quadriparesis, learning disability, epilepsy, and intractable seizures. Complex partial seizures and drop attacks are the most common seizure types. Hypotonia, microcephaly, IS, and learning disabilities are seen in lissencephaly. Severe forms such as Miller–Dieker syndrome due to deletion or mutations of the LIS1 gene on chromosome 17 characterized by facial dysmorphic features can have various seizure types and even premature death. Type I (classic) lissencephaly typically presents with marked hypotonia and paucity of movement. Type II lissencephaly is associated with muscular-dystrophy-like syndromes and includes Walker–Warburg syndrome, Fukuyama syndrome, and muscle–eye–brain (MEB) disease. FCD type I may be characterized by subtle blurring of the gray–white junction with typically normal cortical thickness, moderately increased white matter signal hyperintensities on T2/FLAIR images, and decreased signal intensity on T1-weighted images. FCD type IIA cortical dysplasias are characterized by marked blurring of the gray–white junction on T1 and T2-FLAIR images due to hypo- or dysmyelination of the subcortical white matter with or without cortical thickening. Here, the increased white matter signal changes on T2-weighted and FLAIR images frequently taper toward the ventricles (aka the transmantle sign), which marks the involvement of radial glial neuronal bands. This radiologic feature differentiates FCD from low-grade tumors. Type II lesions are more commonly seen outside the temporal lobe with predilection for the frontal lobes. Type III FCD is typically associated with another principal lesion such as hippocampal sclerosis, tumor, a vascular malformation, or another acquired pathology during early life. Magnetization prepared rapid acquisition gradient echo (MP-RAGE) sequence can yield high-resolution T1-weighted images for more stable abnormalities of cortical thickness. High-resolution 3D T1-weighted volumetric imaging provides superior gray–white contrast, which is critical to identify subtle cortical malformations in patients with epilepsy. Higher magnetic strengths (3 or 7 Tesla) can detect very subtle cortical dysplasias. Increased signal change is more obvious on T2-weighted images, and FLAIR. Proton density reveals blurring of interphase between gray matter and white matter. MRI in Lissencephaly shows thickened cortex, diminished white matter, and vertical sylvian fissures, giving a typical figure 8 appearance of the brain (Image 8.2C). The histological features of FCD include disruption of cortical lamination; giant neurons, dysplastic “balloon cells” in white matter; excess of neurons in the white matter, causing blurring of the interface between the gray matter and white matter. Images 8.2C and 8.2D: Brain MRI T2-weighted image (8.2C) shows overall paucity of gyri with thickened and flattened appearance. Pattern is more posteriorly affected suggesting LIS1 mutation, and CT head noncontrast axial Images 8.2D) show open lip schizencephaly in the left frontotemporoparietal regions (image credit courtesy Sarah Milla, MD). Treatment of the epilepsy associated with cortical dysplasia is often frustrating, but surgical approaches based on accurately defining epileptogenic regions are proving increasingly successful. AEDs are used to treat seizures but more than 60% to 70% of patients have medically intractable seizures due to FCD. A complete resection of the epileptogenic zone is required to achieve seizure freedom after the epilepsy surgery. Corpus callosotomy and VNS are other options in diffuse or bilateral dysplasias. Functional hemispherectomy is another option for patients with hemimegalencephaly. Genetic diagnosis is important for accurate counseling of families. 1. Taylor DC, Falconer MA, Bruton CJ, et al. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry. 1971;34:369–387. 2. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology. 2004;62:S2–S8. 3. Barkovich AJ, Kuzniecky RI. Neuroimaging of focal malformations of cortical development. J Clin Neurophysiol. 1996;13:481–494. 4. Barkovich J, Kuzniecky RI, Jackson GD, et al. A developmental and genetic classification for malformations of cortical development. Neurology. 2005;65:1873–1887. 5. Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain. 2002;125(8):1719–1732. 8.3 Limbic Encephalitis A 23-year-old female presented with a cluster of seizures. She was otherwise healthy. She had been acting oddly for the past two weeks. She was thinking that her neighbors were spying on her. She was found missing two days prior to her presentation in the emergency room. The patient was diaphoretic on exam and appeared paranoid about hospital staff. Images 8.3A–8.3D: Axial and coronal FLAIR MRIs demonstrate hyperintensity of the hippocampi bilaterally in a patient with limbic encephalitis. Limbic encephalitis (LE) is an inflammatory disorder of the limbic system (Illustration 8.3.1). Two major etiologies of LE are recognized: infectious and autoimmune. In cases of infectious LE, viral agents such as herpes simplex are most often implicated. Autoimmune LE can be further divided into paraneoplastic and nonparaneoplastic forms of the disease. Variable but most commonly include memory loss, personality changes, psychiatric symptoms ranging from depression to frank psychosis, involuntary movements, and seizures. Illustration 8.3.1: Components of the limbic system. Source: Blausen.com. Blausen gallery 2014. Wikiversity Journal of Medicine. 2014. doi:10.15347/wjm/2014.010. ISSN20018762. Several cancer types have been associated with paraneoplastic encephalomyelitis and LE. Underlying tumor is small cell lung cancer in approximately 75% of cases Other tumors include seminoma and other testicular tumors, thymoma, breast cancer, Hodgkin lymphoma, uterine or other gynecological tumors Tumor frequently undiagnosed at the time the neurological syndrome develops The type of associated autoantibody varies with tumor type. Small cell lung cancer usually associated with anti-Hu or CRMP5 antibodies in serum and cerebrospinal fluid (CSF) The clinical presentation varies depending on the areas involved as listed in the following: Temporolimbic regions: LE Brainstem: opsoclonus–myoclonus Cerebellum: cerebellar degeneration Retina: melanoma-associated retinopathy (MAR), carcinoma-induced retinopathy (CAR) Spinal cord: myelopathy Dorsal root ganglia: sensory neuronopathy Neuromuscular junction: Lambert-Eaton myasthenic syndrome Peripheral nerve and muscle: dermatomyositis Multiple levels: encephalomyelitis Brain MRI: Hyperintensities of the medial temporal lobes on T2-weighted images may or may not be present with or without Gd-enhancement. The MRI may be normal in a substantial number of patients. Paraneoplastic LE is associated with the production of various antibodies in association with a tumor. The most common tumors involved are tumors of the lung (specifically small cell tumors), thymus, breast, ovaries, and testis. In young females, ovarian teratomas are frequently implicated. The most commonly implicated antibodies are anti-Ma2, anti-amphiphysin, anti-CV2/CRMP5, LGI-1, and anti-NMDA receptor (Table 8.3.1). Nonparaneoplastic LE is often associated with antibodies against the voltage–gated potassium channel. EEG: nonspecific, focal, or generalized slowing, epileptiform activity, periodic lateralized epileptiform discharges (PLEDs). CSF: may be normal or abnormal, modest protein elevation less than 100 is most common, mild lymphocytic pleocytosis. Exclude metabolic and toxic encephalopathies. Paraneoplastic and autoimmune biomarkers (ie, “paraneoplastic panel” on CSF and serum; see Table 8.3.1). Pan-CT: chest, abdomen, and pelvis; scrotal ultrasound to rule out testicular tumors; mammogram. Table 8.3.1 Various Antibodies Encountered in Patients With Autoimmune Encephalitis Antibody Panel Neuronal Antibodies Panel ANA Anti-dsDNA Rnp/Smith-Ab SS-A and SS-B ANCA (c-ANCA, p-ANCA) ACLA Anti-Hu Anti-Yo Anti-Ri Anti Ma2 Anti-CV2/CRMP5 Anti-NMDA Anti-amphiphysin Anti-LGI-I Anti-CASPR-2 Anti-GAD65 Anti-AMPA Anti-GABA-A, GABA-B Anti-IgLON5 encephalopathy Anti-glycine (a-I subunit) Although controlled trials are lacking, immunosuppressive therapies including intravenous immunoglobulin (IVIG), plasmapheresis, and steroids are commonly used. Cyclophosphamide or rituximab is used if these therapies are not efficacious. Symptomatic treatment includes antipsychotics and antiseizure medications. NueDexta (dextromethorphan/quinidine) can be used for the treatment of pseudobulbar affect. 1. Anderson NE, Barber PA. Limbic encephalitis—a review. J Clin Neurosci. September 2008;15(9):961–971. 2. Toledano M, Pittock SJ. Autoimmune epilepsy. Semin Neurol. June 2015;35(3):245–258. 3. Heine J, Prüss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis—relevance for clinical practice and hippocampal function. Neuroscience. May 2015;309:68–83. pii: S0306-4522(15)00479-0. 4. Ramanathan S, Mohammad SS, Brilot F, Dale RC. Autoimmune encephalitis: recent updates and emerging challenges. J Clin Neurosci. May 2014;21(5):722–730. 5. Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol. June 2014;27(3):361–368. 6. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu—associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore). 1992;71:59. 7. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(Pt. 7):1481. 8. Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10:131. 9. Alamowitch S, Graus F, Uchuya M, et al. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain. 1997;120(Pt. 6):923. 10. Shimazaki H, Ando Y, Nakano I, Dalmau J. Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry. 2007;78:324. 11. Blausen.com. Blausen gallery 2014. Wikiversity Journal of Medicine. 2014. doi:10.15347/wjm/2014.010. ISSN 20018762. 8.4 Status Epilepticus A 36-year-old was transferred from another hospital for continuous generalized seizures. Image 8.4A: EEG clips (bipolar montage) show convulsive status epilepticus; note 2–2.5 Hz generalized spike- and slow-wave discharges in an unresponsive patient. 1. Definition and epidemiology: a. Status epilepticus (SE) is a condition resulting either from the failure of the mechanisms responsible for seizure termination or from the initiation of mechanisms, which lead to abnormally prolonged seizures (after time point t1). Here t1 is considered 5 minutes and SE can have long-term consequences (after time point t2; the second time point is 30 minutes) including neuronal death, neuronal injury, and alteration of neuronal networks, depending on the type and duration of seizures. b. The proposed diagnostic classification system of SE contains four axes: Axis 1—Semiology: forms of SE with prominent motor systems, those without prominent motor systems, and currently indeterminate conditions Axis 2—Etiology: known and unknown causes Axis 3—EEG correlates: name of pattern, morphology, location, time-related features, modulation, and effect of intervention Axis 4—Age: neonatal, infancy, childhood, adolescent and adulthood, and elderly c. There are approximately 20 SE cases per 100,000 people in the United States yearly, with higher incidence in early childhood (<5 years) and in the elderly (>65 years). SE occurs most commonly in children less than a year of age (135–156 in 100,000/year). 2. Subgroup: a. By seizure phenotype, SE is classified to three main subtypes. The most commonly reported form (~50%) is generalized convulsive SE (GCSE). Convulsive SE is clinically obvious initially; however, after 30 to 45 minutes of continuous seizures clinical signs may become subtle or absent. The only sign may be twitching of eyes or fingers, or autonomic manifestation such as tachycardia, papillary dilatation, or hypertension. In such cases, a continuous electroencephalogram (EEG) would be the only way to monitor seizure activities. b. Focal motor SE (FMSE), or epilepsy partialis continua, is a continuous muscle twitching without generalization, which is frequently seen in a single limb or a side of the face. This subtype is relatively uncommon, and how aggressively one needs to treat FMSE largely depends on the clinical context. c. The last subtype, non-convulsive SE (NCSE), represents a heterogeneous group of nonmotor seizures. It includes primary generalized SE (eg, absence SE), secondary generalized SE, and complex partial SE. Since their clinical presentation varies widely, ranging from somnolent to comatose status, the only way to diagnose NCSE is electroencephalogram (EEG). For this reason, NCSE is likely under-recognized, particularly in critically ill patients with impaired mental status. Five to ten percent of comatose patients in the intensive care unit (ICU), and up to 34% of neurological ICU patients may be in NCSE if examined by EEG. In patients with severe anoxic-ischemic encephalopathy, NCSE is associated with poor neurological outcome. d. The refractory status is when it does not break with using first- and second-line AEDs such as lorazepam, diazepam, and IV load of phenytoin and phenobarbital. The super-refractory SE is when even IV anesthetics such as propofol, Versed, and pentobarbital fail to control seizures. 3. Etiology: a. The most common risk factor of SE is a prior history of epilepsy (22%–26%). However, more than half of SE occurs in people without prior seizures. In adults, most common causes of SE are cerebrovascular accidents (25%), change in medications (18%–20%), alcohol/substance withdrawal (10%–13%), and less frequent causes include anoxia, metabolic derangement, infection, trauma, and tumor, in a descending order. In contrast, one-third of pediatric SE cases are due to infection fever (ie, prolonged febrile convulsion [PFC]), followed by low AED levels. 4. Mortality: a. The prognosis of SE is greatly dependent on age, etiology, promptness of treatments, and complications that occur in its course. Short-term mortality, measured as death rate during hospitalization for SE or within 30 days of SE, ranges from 8% to 22% across all age groups. Most of these early deaths occur in those with acute symptomatic etiology. b. Although long-term mortality of SE is not as well studied as short-term outcomes, a population-based cohort study showed that among survivors of the initial 30 days after their first SE, over 40% died in the next 10 years. This is approximately threefold higher mortality compared to the general population. However, serious medical complications during the hospitalization, irreversible neurological damage, and functional deterioration on discharge likely contribute to the long-term outcome. c. Children have a much lower mortality rate (3%–15%) than adults (15%–22%), which is probably due both to their physiologic resilience and to the nature of etiology in this age group. For example, PFCs carry a low mortality rate, rarely last longer than 2 hours, and are generally more responsive to treatments than GCSEs of other etiologies. Etiologies that cause severe persistent systemic disturbances such as anoxia are less common in children yet carry similar mortality as when it occurs in adults. 5. Morbidity: a. Prolonged seizures: Morbidity and mortality rates of SE appear to have crude correlation to its etiology. In the past, NCSE has been thought to be a benign condition. However, recent studies indicate that even NCSE is associated with significant complications. b. Unremitting seizure activities result in cardiorespiratory, autonomic, and metabolic complications as well as irreversible neuronal injury. Prolonged convulsive seizures may lead to hypothermia, acidosis, rhabdomyolysis, renal failure, trauma, and pulmonary aspiration. Prolonged seizure activities lasting as little as 30 to 60 minutes may result in irreversible neuronal damage secondary to excitotoxicity, apoptosis, synaptic reorganization, and impaired protein and DNA synthesis. Seizures lasting longer than 1 hour are predictive of poor outcome. c. Certain regions of the brain are more likely to be affected by SE than others. They include hippocampal complex, amygdala, thalamus, and cerebellar pyramidal cells, all of which have abundant receptors for excitatory neurotransmitters and are therefore more prone to excitotoxicity and other mechanisms of insult. Some victims of SE suffer from irreversible dysfunction in memory, balance, affect, and cognition. PFCs, considered benign in the past, are thought to result in acute hippocampal injury and MTS, later leading to development of temporal epilepsy. A causal association, however, is still being argued, since genetic predisposition is an important cause both for febrile seizures and MTS. d. Since SE often requires an intensive level of care and prolonged hospitalization, there are additional complications associated with treatment. Adverse effects of anticonvulsant drugs, drug–drug interactions, ventilator-associated pneumonia, and other nosocomial infections are just a few examples. SE is a true neurological and medical emergency, requiring prompt recognition and initiation of treatments. Many old and newer anticonvulsant drugs have been studied for their effectiveness in SE. Most commonly used agents are summarized in Table 8.4.1. In general, IV benzodiazepines are the first-line agents for GCSE in adults. Lorazepam is a preferred agent to diazepam and midazolam because of its better water solubility and hence a longer serum half-life (4–6 hours). About 65% of GCSE can be terminated with the initial benzodiazepine therapy. If seizures continue after the administration of lorazepam, IV phenytoin or fosphenytoin is the next choice of agent. Although not as widely available, fosphenytoin has advantages over phenytoin in that it can be infused three times faster, can be administered intramuscularly, and has a better side-effect profile. Following a loading dose, an additional smaller dose (ie, 25%–50% of the initial dose) of phenytoin or fosphenytoin can be given. For continuing seizures, a loading dose of IV phenobarbital may be administered, followed by a second dose (ie, 25%–50% of the initial dose). If this fails to break SE, general anesthesia may be the next line of agent. The first-, second-, and third-line agents used in SE are listed in Table 8.4.1. Alternatively, newer agents with broad spectrum, such as IV valproic acid or levetiracetam, can be used at this point, depending on past experiences, drug availability, and personal preferences. At any point during the treatment, an emergency intubation may be necessary. If the patient has seizures continuing over an hour on presentation, has severe systemic derangement, or develops SE while in the ICU, the treating physician can immediately proceed with continuous infusion of general anesthetic agents such as propofol, midazolam, or phenobarbital. Table 8.4.1 Treatment of Status Epilepticus I/V Lorazepam 0.1 mg/kg (4–8 mg loading dose; not more than 8 mg/24 h) I/V Phenytoin Loading dose: 20 mg/kg IV Maximum infusion rate: 50 mg/min I/V Fosphenytoin Loading dose: 20 mg/kg IV Maximum infusion rate: 150 mg/min I/V Valproate Loading dose: 20 mg/kg IV, higher doses 30–60 mg/kg can be used Infusion rate: 5 mg/kg/min I/V Phenobarbital Loading dose: 15 mg/kg to 20 mg/kg Maximum rate: 50 mg/min to 100 mg/min Midazolam (Versed) I/M, nasal, buccal 0.2 mg/kg (nasal/buccal faster than IM) Continuous IV midazolam Infusion* Bolus dose: 0.2 mg/kg, repeat boluses of 0.2 mg/kg to 0.4 mg/kg every 5 min until seizures stop, up to a maximum total loading dose of 2 mg/kg Initial infusion rate: 0.1 mg/kg/h Maintenance: 0.05 mg/kg/h–2.9 mg/kg/h (continuous IV rate should be increased by 20%) Continuous IV propofol infusion* Bolus dose: 1 mg/kg Repeat 1 mg/kg to 2 mg/kg boluses q 3–5 min until seizures stop, up to 10 mg/kg Initial infusion rate: 2 mg/kg/h Continuous infusion rate: 1 mg/kg/h to 15 mg/kg/h Do not exceed >5 mg/kg/h for >48 h Continuous IV pentobarbital infusion* Loading dose: 5 mg/kg, repeat 5 mg/kg boluses until seizures stop. Maximum bolus rate: 25 mg/min to 50 mg/min (based on blood pressure) Initial infusion rate: 1 mg/kg/h Maintenance rate: 0.5 mg/kg/h to 10.0 mg/kg/h *All continuous infusions should be kept on a steady dose for 12 to 24 hours and slow withdrawal of infusions is recommended over 24 hours. If seizures return, try even slower withdrawal. If patients with known epilepsy develop SE, it is often due to a low serum level of their AEDs, and the administration of their home medications may be necessary unless one is absolutely sure of their compliance. For absence SE, first-line agents such as sodium valproate, ethosuximide, and benzodiazepines are effective. Other agents such as zonisamide, levetiracetam, lamotrigine, lacosamide, and topiramate can also be helpful. On the other hand, phenytoin, carbamazepine, oxcarbazepine, and tiagabine can exacerbate absence seizures and should be avoided. Out of the third-generation AEDs (perampanel, eslicarbazepine, lacosamide), only lacosamide is available in the IV form and is being used off-label in SE. 1. Brenner RP. EEG in convulsive and nonconvulsive status epilepticus. J Clin Neurophysiol. September–October 2004;21(5):319–331. 2. Kaplan PW. The EEG of status epilepticus. J Clin Neurophysiol. June 2006;23(3):221–229. 8.5 Infantile Spasms A 5-month-old baby girl brought to a clinic for complaints of unusual movements is observed to have clusters of stereotyped posturing with eye-rolling, neck and hip flexion, and bilateral arm extension shortly after waking not associated with feeding; afterwards she is often more fussy or subdued than usual. There are no neurocutaneous abnormalities noted on exam. Image 8.5A: Axial T2 MRI demonstrating lissencephalpy (one of many structural abnormalities potentially associated with infantile spasms). Infantile spasms (IS) are the most common early-onset epileptic encephalopathy. Epilepsy is more common in infancy than any other time in childhood, and epileptic spasms are the most common single type of seizure. IS may present as a component of West syndrome, a clinical triad consisting of epileptic spasms, hypsarrhythmia on EEG, and developmental delay or regression. There are many potential underlying causes of IS. The majority (~60%) of cases are due to structural or metabolic etiologies; the rest are either linked to other genetic defects or as-of-yet unknown causes (categorized as idiopathic). IS typically present as clusters of stereotyped brief seizures, which can include flexion or extension of the arms, legs, torso, and head. Clusters often occur upon awakening or around sleep–wake transitions. Spasms consist of a sharp jerk followed by up to ~1 to 2 seconds of tonic posturing. Image 8.5B: Background hypsarrhythmia; note the high voltage (>200 mV), lack of anterior to posterior organization, and multifocal epileptic activity. This is an interictal period with no spasms. Overall incidence of ~2 to 3 per 10,000 live births, with onset typically between 3 to 7 months of age (~93% before 2 years of age). Patients may have a known neurological diagnosis or syndromic findings including (but not limited to): Tuberous sclerosis Down syndrome Autism Intellectual disability The most common causes of IS include: Hypoxic-ischemic encephalopathy (~10%) Chromosomal anomalies (~8%) CNS malformation (~8%) Perinatal stroke (~8%) Tuberous sclerosis (~7%) Periventricular leukomalacia or hemorrhage (~5%) Immune-mediated (rare) Other rare neurometabolic or genetic syn-dromes Regardless of cause, neurodevelopmental outcome is generally poor. The most important factor in long-term outcome is early and effective control not only of spasms but hypsarrhythmia as well. Patients with an underlying identified structural or metabolic etiology tend to be more refractory to treatment. A significant portion of infants go on to have long-term epilepsy. In most cases epileptic spasms eventually resolve with time. Spasms are often replaced with new (or multiple) seizure types. A significant proportion may evolve to LGS. The very first step in diagnosis is typically EEG or video EEG monitoring, to both characterize the paroxysmal episodes concerning for epileptic spasms and also assess the background for potential hypsarrhythmia. Hypsarrhythmia (Image 8.5B) is a chaotic high voltage multifocal epileptic interictal background seen between spasms; less typical findings may be referred to as modified or atypical hypsarrhythmia. Clinical epileptic spasms are typically associated with high-amplitude epileptic activity followed by diffuse attenuation known as an “electrodecremental response” during which the very abnormal-appearing background hypsarrhythmia is replaced with a more suppressed background (Image 8.5C). Consider potential supplementation for metabolic abnormalities or vitamin deficiencies (pyridoxine, for example), which may lead to rapid improvement in the EEG. Neuroimaging is recommended for any infant presenting with epilepsy, including IS. Image 8.5C: Electroclinical infantile spasm with onset ~2 seconds in with high-amplitude generalized epileptic activity followed by diffuse attenuation and slowing; same patient and scale as in Image 8.5B. MR is typically the most appropriate initial imaging modality, though in urgent or extenuating circumstances ultrasound or CT imaging may be considered. Once feasible, MR brain imaging should be obtained. Subsequent imaging for further workup (including potential surgical evaluation) may include functional magnetic resonance imaging (fMRI), PET, magnetoencephalogram (MEG), or SPECT Electroencephalography–functional magnetic resonance imaging (EEG–fMRI) has demonstrated epileptiform discharges associated with occipitally predominant positive blood oxygen level dependent (BOLD) signal changes in the cerebral cortex while high-amplitude slow-wave activity in hypsarrhythmia is associated with BOLD signal changes in the brainstem, putamen, and thalamus. Early PET studies have shown areas of focal cortical hypometabolism and subcortical hypermetabolism (in the putamen and brainstem) associated with hypsarrhythmia. Expansion of glucose hypometabolism may be seen on PET with persistent epilepsy. Potential causes identifiable on imaging considered sufficient for diagnosis include: Tuberous sclerosis Evidence of prior hyoxic ischemic encephalopathy (HIE) or other cerebrovascular event Clear underlying structural abnormalities Genetic evaluation for any infantile-onset epileptic encephalopathy without identified cause (including IS) should be undertaken with access to genetic counseling by trained personnel, as diagnosis of specific underlying neurometabolic causes may alter specific treatments and outcomes. Primary and secondary level investigations should include serum glucose, hematologic screening, liver function tests, ammonia, urinalysis, serum lactate and pH, arterial gases, plasma electrolytes including anion gap measurement, and CSF analysis including glucose (with comparison to plasma to rule out hypoglycorrhachia). Tertiary and quaternary level investigations should include any additional amino or organic acidopathy testing as well as specific enzymatic studies (which may require biopsies) or genetic screening including more broad sequencing and analysis. Specific metabolic conditions associated with IS include biotinidase deficiency, Menkes disease, mitochondrial respiratory chain diseases, amino acidopathies, and organic acidurias. The shorter the interval between spasm onset and commencement of treatment, the better the potential developmental outcome, with the potential for meaningful improvement not only in seizures but in cognition and behavior. Barring a specific diagnosis with alternative primary treatment, ACTH historically has been considered preferable for the short-term control of spasms (initially studied in high doses). Low-dose ACTH appears to be as effective as high-dose ACTH yet has a more tolerable side-effect profile. Oral steroids (in particular, the prednisolone dosing in Table 8.5.1) are probably also effective for short-term control, and should certainly be considered if ACTH is not feasible. Table 8.5.1 Treatments With Dosing for Infantile Spasms With Corresponding Side Effects Treatment Typical U.S. Dosing Range Potential Side Effects High-dose ACTH ~75–150 IU/m2/day for ~2 weeks followed by a gradual taper Depression of the immune system, hypertension, behavior change/irritability, increased appetite/weight gain, sleep disturbance, potential adrenal suppression requiring taper Low-dose ACTH ~ 20–40 IU/day (also with potential taper) Theoretically similar to high-dose ACTH but to a significantly lesser degree of magnitude Oral steroids Preferred: Prednisolone ~40–60 mg/day Other options: —Prednisone 2 mg/kg/day —Methylprednisolone 20mg/kg/day IV for 3 days followed by a steroid taper Dose-dependent depression of the immune system, hypertension, behavior change/irritability, increased appetite/weight gain, sleep disturbance, potential adrenal suppression requiring taper Vigabatrin ~50–150 mg/kg/day Symptomatic and asymptomatic visual field defects (loss of peripheral vision); sedation or other behavioral changes; abnormalities on MRI imaging Topiramate Typically ~5–9 mg/kg/day but described in infants up to ~24 mg/kg/day Appetite and weight loss, confusion/impaired cognition/sedation, glaucoma, renal calculi Valproate ~30 mg/kg/day reportedly effective; dosing to achieve therapeutic levels may range from ~15 to 60 mg/kg/day Hepatotoxicity (particularly if concern for underlying neurometabolic disease), hyperammonemia, sedation, pancreatitis, encephalopathy, thrombocytopenia Ketogenic diet High fat, adequate protein, low carbohydrate diet (delivered in variable ratios). Constipation, hyperlipidemia, dehydration, renal calculi, slowed growth/weight gain, bone fractures ACTH, adrenocorticotropic hormone. Vigabatrin is also effective for short-term control of spasms; it is typically considered second-line following ACTH/steroids with the exception of patients with tuberous sclerosis. In patients with tuberous sclerosis, vigabatrin is considered first-line treatment. Patients are typically re-evaluated frequently (initially at ~2-week intervals) to assess response to treatment, both with regard to epileptic spasms and background hypsarrhythmia. Third- or fourth-line therapies include topiramate or valproate, particularly in infants with severe or static neurological insults without prior evidence of regression. Additional subsequent treatment options for refractory cases include benzodiazepines, levetiracetam/other antiepileptics, immunomodulatory agents as warranted (IVIG, plasmapheresis), epilepsy surgery—for appropriate candidates—or ketogenic diet (KD). 1. Wilmhurst JM, Gaillard WD, Vinayan KP, et al. Summary of recommendations for the management of infantile seizures: Task force report for the ILAE commission of pediatrics. Epilepsia. 2015;56(8):1185–1197. 2. Galanopoulou AS, Moshé SL. Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: a view from preclinical studies. Neurobiology of Disease. 2015;79:135–149. 3. Widjaja E, Go C, McCoy B, Snead OC. Neurodevelopmental outcome of infantile spasms: a systematic review and meta-analysis. Epilepsy Research. 2015;109:155–162. 4. Nieh SE, Sherr EH. Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics. 2014;11:796–806. 5. Siniatchkin M Capovilla G. Functional neuroimaging in epileptic encephalopathies. Epilepsia. 2013;54(Suppl. 8):27–33. 6. Riikonen R. Recent advances in the pharmacotherapy of infantile spasms. CNS Drugs. 2014;28:279–290. 7. Pavone P, Striano P, Falsaperla R, Pavone L, Ruggieri M. Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013. Brain & Development. 2014;36:739–751. 8. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms (Review). The Cochrane Library. 2013;6:1–69. 9. Wanigasinghe J, Arambepola C, Ranganathan SS, Sumanasena S, Attanapola G. Randomized, single-blind, parallel clinical trial on efficacy of oral prednisolone versus intramuscular corticotropin on immediate and continued spasm control in West syndrome. Pediatric Neurology. 2015;53:193–199. 8.6 Lennox–Gastaut Syndrome A 4-year-old boy with history of IS presents for evaluation of ongoing seizures. His mother reports that he has frequent seizures throughout the day and night. Most seizures are very brief jerks, sometimes resulting in falls. He also has periods of staring lasting seconds to sometimes a minute. His other medical history includes speech and gross motor delay. He has had several AED trials without improvement in his seizures. Images 8.6A–8.6D: Brain MRI axial diffusion-weighted and apparent diffusion coefficient (ADC) images showing diffusion positive lesions in thalami (8.6A), cerebellar tonsils (8.6B), and drop-out signal in the corresponding regions on ADC (8.6C and 8.6D). Lennox–Gastaut Syndrome (LGS) is a childhood epileptic encephalopathy characterized by a triad: Multiple seizure types, which are often refractory to treatment Interictal slow spike and wave pattern (2.5 Hz) with overall slow background Image 8.6E: Bipolar montages showing generalized polyspikes/spikes and slow waves, which are maximal in the frontal and frontocentral regions. Image 8.6F: Bipolar montage shows low-amplitude 15–20 Hz fast activity in the parasagittal regions admixed with muscle artifacts during a tonic seizure. Patient had stiffening of the whole body, which lasted for about 15 seconds; the red bar represents the clipped segment of the seizure onset. Image 8.6G: Bipolar montage shows a brief run of generalized paroxysmal fast activity (GPFA) 10–20 Hz lasting approximately 6 seconds without any clinical correlate during sleep. Cognitive decline Patients with LGS have multiple seizure types including IS; drop attacks are a common presentation caused by tonic, atonic, or less commonly, myoclonic seizures (see Table 8.6.1). The majority of patients have at least one episode of SE or nonconvulsive status. GTCs and focal seizures can occur, but are not as frequent as other seizure types. Comorbid conditions may include behavioral, psychiatric, or sleep disorders. The etiology can be idiopathic, or develop from prior brain insults or structural lesions. The onset varies in childhood from 2 to 6 years, and is more common in males. Table 8.6.1 Common Seizure Types and Ictal Patterns (Most Common to Least Common) Seizure Type Ictal Pattern Semiology Tonic Low voltage, fast activity (~10 Hz) Stiffening of trunk, extremities, or whole body; often during sleep Atypical absence Slow spike and slow wave <2.5 Hz Not completely unaware, lasts longer than typical absence, hyperventilation does not provoke them Atonic High voltage, bisynchronous spikes Loss of tone Myoclonic Bisynchronous spike and wave Single movement or clusters Most patients are refractory to medical treatment. Typically patients are treated with broad-spectrum medications because of multiple seizure types, focal as well as generalized. Narrow-spectrum drugs such as carbamazepine can be more effective to treat complex partial seizures bearing in mind that it may worsen other generalized seizure types. Polytherapy is commonly employed and AEDs with least drug-to-drug interactions or synergistic efficacy are chosen (see Table 8.6.2). Topiramate, felbamate, lamotrigine, valproate, and rufinamide are all approved as adjunctive therapy in LGS. Levetiracetam, zonisamide, and clonazepam show some evidence of efficacy also. Table 8.6.2 Commonly Used AEDs in Patients With LGS AED Mechanism of Action Common Side Effects Valproate Increases GABA Thrombocytopenia, hepatic failure, teratogenic, hyperammonemia, encephalopathy Benzodiazepines (especially clobazam) Potentiates GABA CNS depression including drowsiness Lamotrigine Inhibits glutamate and Na+ channels Rash including SJS Felbamate Broad spectrum Aplastic anemia, hepatic failure, loss of appetite, headache, insomnia Topiramate Broad spectrum Paresthesia, somnolence, anorexia, loss of appetite, oligohydrosis, increased risk of kidney stones, cognitive side effects Rufinamide Unknown, in vitro affects sodium inactivation Vomiting, pyrexia, rash CNS, central nervous system; GABA, γ-aminobutyric acid; SJS, Stevens-Johnson syndrome. Other treatment options include vagal nerve stimulator (VNS), corpus callosotomy, and KD. Corpus callosotomy is commonly done in patients with drop attacks or partial seizures with secondary generalization. Table 8.6.3 summarizes the types of disconnection surgeries done in patients with LGS. Outcome is thought to be slightly better with total callosotomy. Adverse effects usually improve with time, and happen in both types of callosotomy. Dietary therapy: The principle of special diet is to change the milieu of brain, which relies on carbohydrates to fats as its primary source of energy. There are multiple theories on how ketosis exerts its antiseizure effects. About 50% of patients notice more than 50% of reduction in their seizures and up to 30% notice 90% of strict protein, calorie, and especially carbohydrate restriction in the setting of a high fat diet is needed for ketosis, and can be difficult to maintain. In 10% of patients with intractable epilepsy, staying on this diet for months or years can result in a sustained seizure freedom, and allow for withdrawal of AEDs. Side effects include weight loss, acidosis, kidney stones (5%), growth slowing, poor bone health, risk of dehydration, and dyslipidemia. Table 8.6.4 summarizes various types of special diets that are used in clinical practice. Some are more stringent like classic KD while others such as low glycemic index treatment (LGIT) are more flexible in carbohydrate and fat intake. KG diet is contraindicated in patients with carnitine deficiency, porphyrias, beta-oxidation disorders, or pyruvate carboxylase deficiency. Table 8.6.3 Types of Corpus Callosotomy Table 8.6.4 Ketogenic Diet and Its Variants The vagus nerve stimulator (VNS) is a device that provides intermittent electrical stimulation of the left vagus nerve, which is effective in reducing seizures, and received Food and Drug Administration (FDA) approval in 1997. The stimulator is similar to a cardiac pacemaker and is surgically implanted subcutaneously. The right vagus nerve is not stimulated because of its rich innervation to the sinoatrial node of the heart. The mechanism by which stimulation reduces seizures is not well established. Adverse effects are generally mild and include hoarseness, throat pain, or a feeling of dyspnea during stimulation. The cost of the device and its implantation may be limiting factors. Clinical trials demonstrate that less than 5% of patients become seizure-free with VNS placement but approximately one-third of patients experience a clinically significant decrease in their seizure frequency. The device may have value for generalized epilepsies, especially LGS and specifically atonic seizures. Many centers will try a VNS prior to a callosotomy for intractable atonic seizures. VNS has a responder rate of 40% (ie, 40% of patients have a 50% or more decrease in their seizures). 1. Al-Banji M, Zahr DK, Jan MM. Lennox-Gastaut syndrome management update. Neurosciences. July 2015;20(3):207–212. 2. Arzimanoglou A, Guerrini R, Aicardi J. Lennox-Gastaut syndrome. In: Aicardi’s Epilepsy in Children. Philadelphia, PA: Lippincott Williams & Wilkins, 2004:38–50. 3. Asadi-Pooya AA, Sharan A, Nei M, Sperling MR. Corpus callosotomy. Epilepsy and Behavior. August 2008;13(2):271–278. 4. Guerrini R, Pellock JM. Chapter 11. Age-related epileptic encephalopathies. In: Handbook of Clinical Neurology. 2012;107:179–193. 5. Malmgren K, Rydenhag B, Hallböök T. Reappraisal of corpus callosotomy. Curr Opin Neurol. April 2015;28(2):175–181. 6. Montouris GD, Wheless JW, Glauser TA. The Efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut Syndrome. Epilepsia. 2014;55(Suppl. 4):10–20. 7. Werz MA, Pita, IL. Chapter 7. Lennox-Gastaut syndrome. Epileptic Syndromes. Saunders; 2010:33–41. 8. Winesett SP, Bessone SK, Kossoff EH. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev Neurother. June 2015;15(6):621–628. 8.7 Childhood Absence Epilepsy A 6-year-old female presented with frequent brief episodes of staring. Image 8.7A: EEG tracing with bipolar montage shows generalized regular and symmetrical spikes/polyspikes and slow waves maximal in the frontal and frontocentral regions. Absence seizures (see Table 8.7.1) comprise 2% to 15% of childhood epilepsy, which is 2 to 5 times more common in girls. About 15% to 40% of patients with these epilepsies have a family history of epilepsy. Onset is typically between 4 and 10 years of age. Most patients have normal neurological examinations and normal cognition. Childhood absence epilepsy is caused by abnormalities in T-type calcium channels, which are responsible for rhythmic depolarizing activity in the thalamic neurons. Inherited in autosomal-dominant pattern with incomplete penetrance chromosomes 20q, 16p13.3, and 8q24.3. A mutation in the GABA (A) receptor gene GABRB3 has been found in Mexican families with childhood absence epilepsy. Mutations showed hyperglycosylation in vitro, with reduced GABA-evoked current density from whole cells. Expression of this gene in the developing brain may help explain an age-related onset and remission in childhood absence epilepsy. Table 8.7.1 Classification of Absence Seizures Absence Typical: 3 Hz spike and slow wave Absence with special features Myoclonic absence The episodes are characterized by very brief episodes of sudden behavioral arrest, blank stare, and motionless state with loss of awareness. Loss of postural tone, automatisms, and eye flutter, or eyelid myoclonia can be seen. About 3% may experience GTCs. The staring spells start and end abruptly and last for 5 to 10 seconds and up to hundreds of seizures can occur per day. Patients have no preceding aura and no postictal phase unlike complex partial seizures, which are typically characterized by auras and can have postictal symptoms. Seizures can be provoked by hyperventilation in approximately 90% of children. Absence of SE is characterized by sustained impairment of consciousness associated with generalized 3 Hz spike and waves. Patients often exhibit facial twitching, eye blinking, staring, and automatisms. EEG shows classic 3 Hz generalized spike- and slow-wave pattern. Otherwise, these patients have normal posterior dominant rhythm. The epileptiform discharges are generalized in distribution but typically have maximal field in frontal and frontocentral regions (see EEG in Image 8.7A). The epileptiform discharges are typically provoked by hyperventilation. Primary drugs of choice are ethosuximide, valproic acid, and lamotrigine. Initial trial with ethosuximide (T-type calcium channel blocker) because of fewer incidences of side effects. Treatment is usually with IV lorazepam or valproic acid. Duration of therapy is variable, although the general rule is to taper off therapy after 2 years of seizure freedom. About 80% of patients outgrow this form of epilepsy. Children with early onset have the best prognosis with complete remission 2 to 6 years after onset. Onset of absence seizures before age 3 years is associated with neurodevelopmental abnormalities and other seizure types such as atonic or myoclonic epilepsy, can be refractory to treatment, and carry a poorer prognosis. Refractory absences resistant to medical treatment may be associated with SCNA1 mutation and glucose transporter defect type 1. Rufinamide or KD may be effective in patients with absence and atypical absences associated with LGS. 1. Fong GC, Shah PU, Gee MN, et al. Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4-Hz spike and multispike-slow wave complexes: linkage to chromosome 8q24. Am J Hum Genet. October 1998;63(4):1117–1129. 2. Wallace RH, Marini C, Petrou S, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet. May 2001;28(1):49–52. 8.8 Rasmussen’s Encephalitis An 8-year-old boy presented with medically intractable partial epilepsy. Over the next several months, he developed gradual loss of language skills and was found to have weakness of the right side of his body. Images 8.8A–8.8C: Coronal and axial FLAIR images demonstrate hyperintensty in the left insular cortex and temporal lobe; Image 8.8D shows left modified hemispherectomy. Rasmussen’s encephalitis (RE) develops from a region of inflammation that is localized to one cerebral hemisphere. However, very young children (<2 years), adolescents, and young adults can have bilateral involvement. Lobar and brainstem variants have also been described. It affects children younger than 10 years, with the average age of onset being 6 years. In around 10% of cases of RE, the disease starts after the age of 12 to 13 years, with onsets occurring as late as in mid-30s. It is thought to be due to either a chronic viral infection or an autoimmune response against glutamate receptors. Typically, the central cortex is implicated early in the disease and involves other areas gradually. Patients suffer from either simple or complex partial seizures. Recurrent focal motor seizures, termed epilepsia partialis continua, are common, and often do not respond to AEDs. Patients eventually develop motor, sensory, or language dysfunction due to progressive nature of the disease, which becomes evident on serial neuroimaging. Symptoms progress over the course of 1 year. In very young children less than 2 years of age, adolescents, and adults, bilateral cerebral hemispheres may be involved. MRI shows hyperintensity on T2-weighted images in the affected hemisphere. There is no enhancement with the addition of contrast, though there may be restricted diffusion on diffusion-weighted images. During the acute stage, inflammation is evident as FLAIR signal hyperintensity, disproportionately involving the gray matter. In the chronic stage, this inflammation resolves and atrophy ensues. There is progressive atrophy of the cerebral hemisphere. In 10% of the patients, the changes can be seen bilaterally. A brain biopsy may be needed to make the diagnosis in equivocal cases. The mainstay of treatment is glucocorticoids, IVIG, plasmapheresis, and immunosuppressive therapy (rituximab, tacrolimus, natalizumab) in an attempt to control the inflammation. In some patients, seizures are refractory to aforementioned treatments and standard antiepileptic medications. Excision techniques such as anatomical hemispherectomy and hemidecortication or disconnection techniques such as functional hemispherectomy and hemispherotomy are effective in controlling seizures with RE (see Table 8.8.1). Table 8.8.1 Various Excision and Disconnection Epilepsy Surgeries Surgical Technique Comments Anatomic hemispherectomy Removal of hemisphere sparing ipsilateral basal ganglia and thalamus; carries greatest intraoperative risks; blood loss is managed by early occlusion of vascular supply (ACA, MCA, PCA) Functional hemispherectomy (Rasmussen) Extensive cortical resection in temporal and central cortex (frontal/parietal) with disconnection of residual frontal and occipital cortex by transecting white matter fibers Hemispherotomy Disconnecting the hemisphere with minimal brain tissue removal; approaches can be vertical and peri-insular (lateral) Hemidecortication Removal of the whole hemisphere with sparing of the white matter; avoids opening of the lateral ventricle ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery. 1. Ciliberto M, Powers AK, Limbrick DL, Titus J, Munro B, Smyth MD. Palliative functional hemispherotomy in patients with bilateral seizure onset. J Neurosurg Pediatr. 2012;9:381–388. 2. Limbrick DD, Narayan P, Johnston JM, Ojemann JG, Park TS, Smyth MD. Outcomes following hemispherotomy: the St. Louis Children’s Hospital experience. (Abstract) Child’s Nervous System. 2007;23(9):1062. 3. Limbrick DD, Narayan P, Powers AK, et al. Hemispherotomy: efficacy and analysis of seizure recurrence. J Neurosurg Pediatr. 2009;4:323–332. 4. Narayan P, Isik U, Trevathan E, et al. Functional hemispherectomy for epilepsy in childhood: Institutional experience [Platform presentation]. Salt Lake City, UT: Joint Pediatric Section; 2003.
Case History
Diagnosis: Temporal Lobe Epilepsy
Introduction
Focal Seizures
Generalized Seizures
Clinical Presentation
Radiographic Appearance and Diagnosis
Treatment
ictal
interictal
SISCOM
Hypoperfusion of the seizure focus
Subtraction ictal SPECT co-registered to MRI
References
Case History
Diagnosis: Frontal Lobe Epilepsy Due to Focal Cortical Dysplasia
Introduction
Clinical Presentation
Radiographic Appearance and Diagnosis
Treatment
References
Case History
Diagnosis: Limbic Encephalitis
Introduction
Clinical Presentation
Radiographic Appearance and Diagnosis
Treatment
References
Case History
Diagnosis: Convulsive Status Epilepticus
Introduction
Treatment
References
Case History
Diagnosis: Infantile Spasms
Introduction
Clinical Presentation
Radiographic Appearance and Diagnosis
Treatment
References
Case History
Diagnosis: Lennox–Gastaut Syndrome
Introduction
Clinical Presentation
Treatment
References
Case History
Diagnosis: Childhood Absence Epilepsy
Introduction
Atypical: Slow 2–2.5 Hz spike and slow wave
Eyelid myoclonia
Jeavons syndrome
Clinical Presentation
Electrographic Appearance and Diagnosis
Treatment
References
Case History
Diagnosis: Rasmussen’s Encephalitis
Introduction
Clinical Presentation
Radiographic Appearance and Diagnosis
Treatment
References
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree